Evidence map›Paper›PMID 15972968›Full record

ArticleThe American journal of pathology2005

c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis.

Christoffer Gebhardt, Ute Breitenbach, Karl Hartmut Richter, Gerhard Fürstenberger, Cornelia Mauch, Peter Angel, Jochen Hess

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma.Current treatment options in oncology · 2021
    Review
  4. Upregulation of long noncoding RNAAnnals of translational medicine · 2020
    Article
  5. Article
  6. Article
  7. Rab11 Functions as an Oncoprotein via Nuclear Factor kappa B (NF-κB) Signaling Pathway in Human Bladder Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  8. Long non-coding RNAOncotarget · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Integrin traffic - the update.Journal of cell science · 2015
    Review
  14. Rab11 in disease progression.International journal of molecular and cellular medicine · 2015
    Review
  15. Integrin trafficking and tumor progression.International journal of cell biology · 2012
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Christoffer GebhardtDivision of Signal Transduction and Growth Control, German Cancer Research Center, Heidelberg, Germany.
Ute Breitenbach
Karl Hartmut Richter
Gerhard Fürstenberger
Cornelia Mauch
Peter Angel
Jochen Hess
German Cancer Research Center · DEHeidelberg University · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant transformation of mouse skin by tumor promoters and chemical carcinogens, such as the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), is a multistage process leading to the formation of squamous cell carcinomas. It has been shown that mice lacking the AP-1 family member c-Fos exhibit an impaired transition from benign to malignant skin tumors. Here, we demonstrate enhanced expression of the small Ras-related GTPase Rab11a after short-term TPA treatment of mouse back skin. Expression of Rab11a in vivo and in vitro critically depended on c-Fos, because TPA application to the back skin of c-Fos-deficient mice and to mouse embryonic fibroblasts did not induce Rab11a mRNA or protein expression. Moreover, dexamethasone, which is a potent inhibitor of AP-1-mediated transactivation that exhibits anti-inflammatory and anti-tumor promoting activities, inhibited TPA-induced expression of Rab11a. Within the Rab11a gene promoter, we identified a functional AP-1 binding element that exhibited elevated c-Fos binding activity after TPA treatment of keratinocytes. Enhanced expression was not restricted to chemically induced mouse skin tumors but was also found in tumor specimens derived from patients with epithelial skin tumors. These data identify Rab11a as a novel, tumor-associated c-Fos/AP-1 target and may point to an as yet unrecognized function of Rab11a in the development of skin cancer.

Indexed as

AnimalsBlotting, NorthernBlotting, WesternCarcinogensCells, CulturedCell Transformation, NeoplasticElectrophoretic Mobility Shift AssayFemaleFibroblastsFluorescent Antibody TechniqueHumansIn Situ HybridizationKeratinocytesMiceMice, TransgenicPromoter Regions, GeneticCarcinogensProto-Oncogene Proteins c-fosrab11 GTP-Binding Proteinsrab GTP-Binding ProteinsTetradecanoylphorbol Acetate

Identifiers

PMID15972968
PMCPMC1603444
OpenAlexW2068136966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.